Patent Assignment
Reel/Frame 024541/0922
Change of Name
Recorded: 2010-06-16
Received: 2010-06-16
Pages: 11
Assignor
WYETH
Executed: 2009-11-09
Assignee
WYETH LLC
FIVE GIRALDA FARMS, MADISON, NJ, 07940, UNITED STATES
Covered Properties
(100)
Sulfonylated Heterocycles Useful for Modulation of the Progesterone Receptor
Application:
12/787,803 →
A Method of Increasing Trabecular Bone Density in a Patient in Need Thereof by an Antibody Against Gdf-8
Application:
12/785,975 →
1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
Application:
12/662,971 →
Thioamide Derivatives as Progesterone Receptor Modulators
Application:
12/698,472 →
Recombinant Lubricin Molecules and Uses Thereof
Application:
12/624,112 →
Recombinant Lubricin Molecules and Uses Thereof
Application:
12/622,141 →
Purification of Acidic Proteins Using Ceramic Hydroxyapatite Chromatography
Application:
12/608,093 →
Humanized Anti-5T4 Antibodies and Anti-5T4/Calicheamicin Conjugates
Application:
12/580,702 →
Benzimidazole Anthelmintic Compositions
Application:
12/573,289 →
Indole Acetic Acids Exhibiting CRTH2 Receptor Antagonism and Uses Thereof
Application:
12/566,566 →
Polymorphic Form D of Bazedoxifene Acetate and Methods of Preparing Same
Application:
61/244,961 →
Enantiomers of O-Desmethyl Venlafaxine
Application:
12/554,104 →
Aryl Sulfamide Derivatives and Methods of Their Use
Application:
12/548,844 →
Immunological Composition
Application:
12/543,536 →
Process for the Synthesis of C-2, C-3 Substituted N-Alkylated Indoles Useful as CPLA2 Inhibitors
Application:
12/542,914 →
Processes for the Convergent Synthesis of Calicheamicin Derivatives
Application:
12/583,237 →
GASP1: a Follistatin Domain Containing Protein
Application:
12/540,606 →
ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272
Application:
12/539,914 →
Pyrrolo[4,3,2-De]Quinolin-8-Amine Compounds and Methods of Their Preparation and Use
Application:
12/539,869 →
Methods for the Use of Inhibitors of Cytosolic Phospholipase A2
Application:
12/539,074 →
Lyophilization Above Collapse
Application:
12/536,321 →
Cyanopyrrole Containing Cyclic Carbamate and Thiocarbamate Biaryls and Methods for Preparing the Same
Application:
12/508,679 →
Biosynthetic Gene Cluster for the Production of a Complex Polyketide
Application:
12/508,735 →
Device and Method for Controlling Insects
Application:
12/505,890 →
Src Activation for Determining Cancer Prognosis and as a Target for Cancer Therapy
Application:
12/503,019 →
(2-Aryl-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Morpholine Compounds, Their Use as Mtor Kinase and PI3 Kinase Inhibitors, and Their Syntheses
Application:
12/496,675 →
Humanized Anti-5T4 Antibodies and Anti-5T4/Calicheamicin Conjugates
Application:
12/496,609 →
Tanaproget Derivatives, Metabolites, and Uses Thereof
Application:
12/492,229 →
Lyophilization Cycle Robustness Strategy
Application:
12/492,052 →
Inhibitors of Cytosolic Phospholipase A2
Application:
12/488,182 →
Inhibitors of Cytosolic Phospholipase A2
Application:
12/488,020 →
1-Substituted-3-(Naphthalen-1-Ylsulfonyl)-5-(Piperazin-1-Yl)-1H-Indazole Compounds as 5-Hydroxytryptamine-6 Ligands
Application:
12/487,690 →
Amino-Imidazolones for the Inhibition of Beta-Secretase
Application:
12/487,395 →
Thiazolyl-And Oxazolyl-Isoquinolinones and Methods for Using Them
Application:
12/487,247 →
T
Application:
12/487,309 →
Antineoplastic Combinations Containing HKI-272 and Vinorelbine
Application:
12/486,153 →
Heterocyclyl-3-Sulfonylindazoles as 5-Hydroxytryptamine-6 Ligands
Application:
12/483,344 →
Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological, Proliferative, and Inflammatory Disorders
Application:
12/481,211 →
Bmp-12-Related Proteins and Methods of Their Manufacture
Application:
12/480,327 →
Follistatin Domain Containing Proteins
Application:
12/476,489 →
1-Aryl-Or 1- Alkylsulfonylbenzazole Derivatives as 5-Hydroxytryptamine-6 Ligands
Application:
12/475,709 →
Methods of Using Antibodies Against Human Il-22
Application:
12/474,479 →
3-Substituted-1H-Indole Compounds, Their Use as Mtor Kinase and PI3 Kinase Inhibitors, and Their Syntheses
Application:
12/473,605 →
Methods of Treatment Utilizing Binding Proteins of the Interleukin-21 Receptor
Application:
12/472,237 →
Triazine Compounds as PI3 Kinase and Mtor Inhibitors
Application:
12/470,521 →
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Application:
12/471,113 →
Triazine Compounds as PI3 Kinase and Mtor Inhibitors
Application:
12/470,525 →
Substituted N-Heterocycle Derivatives and Methods of Their Use
Application:
12/467,594 →
Glutamate Aggrecanase Inhibitors
Application:
12/465,840 →
Fluoro- and Trifluoroalkyl-Containing Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production and Derivatives Thereof
Application:
12/435,442 →
Serotonergic Agents
Application:
12/435,862 →
Modified and Stabilized Gdf Propeptides and Uses Thereof
Application:
12/434,758 →
Methods for Treating Inflammation
Application:
12/432,617 →
Mammalian Expression Systems
Application:
11/911,908 →
Methods for Enhanced Production of Bone Morphogenetic Proteins
Application:
12/425,056 →
Introducer sheath adapter for the atraumatic delivery of a medical device
Application:
61/212,296 →
Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators
Application:
12/420,085 →
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
Application:
12/393,565 →
Methods for Using Rapamycin Analogues in the Treatment of Neurological Disorders
Application:
12/388,603 →
Serum-free vero cell banking process
Application:
10/583,014 →
Purification of Progesterone Receptor Modulators
Application:
12/369,775 →
Use of Rxr Agonists for the Treatment of Osteoarthritis
Application:
12/369,425 →
Nucleic Acids Encoding Il-13 Binding Agents
Application:
12/358,111 →
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Application:
12/357,853 →
Ephrin and Eph Receptor Agonists for Modulation of Bone Formation and Resorption
Application:
12/354,892 →
3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
Application:
12/354,027 →
COMPOSITIONS CONTAINING O-SULFATE AND O-PHOSPHATE CONTAINING ARYL SULFONAMIDE DERIVATIVES USEFUL AS beta-AMYLOID INHIBITORS
Application:
12/349,850 →
Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
Application:
12/338,226 →
Genetically Modified Attenuated Vesicular Stomatitis Virus, Compositions and Methods of use Thereof
Application:
12/338,367 →
Methods for Packaging Propagation-Defective Vesicular Stomatitis Virus Vectors Using a Stable Cell Line That Expresses G Protein
Application:
12/335,778 →
Methods for Packaging Propagation-Defective Vesicular Stomatitis Virus Vectors
Application:
12/335,763 →
Phenylaminopropanol Derivatives and Methods of Their Use
Application:
12/335,144 →
Rapamycin Derivatives and the Uses Thereof in the Treatment of Neurological Disorders
Application:
12/329,106 →
Crystal structure of human factor VIII and uses thereof
Application:
12/315,847 →
Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological Disorders
Application:
12/276,668 →
Method of Identifying Compounds That Modulate Caspase 9 Activity via Use of a Kosmotropic Salt
Application:
12/269,980 →
KV1.5 Potassium Channel Inhibitors
Application:
12/266,212 →
Mycoplasma Hyopneumoniae Avirulent Adjuvanted Live Vaccine
Application:
12/265,274 →
Aiding Tool for Self-Injection
Application:
29/327,149 →
Antibody to GDF8 and Uses Thereof
Application:
12/262,712 →
Thienopyrimidine and Pyrazolopyrimidine Compounds and Their Use as Mtor Kinase and PI3 Kinase Inhibitors
Application:
12/251,712 →
Maleate Salts of (E)-N-{4-[3-Chloro-4-(2-Pyridinylmethoxy)Anilino]-3-Cyano-7-Ethoxy-6-Quinolinyl}-4-(Dimethylamino)-2-Butenamide and Crystalline Forms Thereof
Application:
12/251,924 →
Amino-5-(6-Membered)Heteroarylimidazolone Compounds and the Use Thereof for Beta-Secretase Modulation
Application:
12/248,996 →
DIPHENYLIMIDAZOLYL COMPOUNDS AS INHIBITORS OF beta-SECRETASE
Application:
12/246,790 →
Chiral Synthesis of Diazepinoquinolines
Application:
12/234,033 →
Azacyclylisoquinolinone and Isoindolinone Derivatives as Histamine-3 Antagonists
Application:
12/208,780 →
Isoquinolinyl and Isoindolinyl Derivatives as Histamine-3 Antagonists
Application:
12/208,794 →
Attenuated Mycoplasma Gallisepticum Strains
Application:
12/207,750 →
Live Attenuated Mycoplasma Strains
Application:
12/207,698 →
Amino-5-[4-(Difluoromethoxy) Phenyl]-5-Phenylimidazolone Compounds for the Inhibition of Beta-Secretase
Application:
12/201,026 →
Compositions and Methods Employing Nmda Antagonists for Achieving an Anesthetic-Sparing Effect
Application:
12/198,489 →
Bicyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors
Application:
12/195,706 →
Interleukin-17F Antibodies and Other Il-17F Signaling Antagonists and Uses Therefor
Application:
12/196,117 →
Naphthylpyrimidine, Naphthylpyrazine and Naphthylpyridazine Analogs and Their Use as Agonists of the Wnt-Beta-Catenin Cellular Messaging System
Application:
12/194,235 →
Nucleic Acid and Amino Acid Sequences Relating to Staphylococcus Epidermidis for Diagnostics and Therapeutics
Application:
12/222,893 →
Nucleic Acid and Amino Acid Sequences Relating to Staphylococcus Epidermidis for Diagnostics and Therapeutics
Application:
12/222,894 →
Use of Perfusion to Enhance Production of Fed-Batch Cell Culture in Bioreactors
Application:
12/188,710 →
Calicheamicin conjugates
Application:
12/221,551 →
Biosynthetic Gene Cluster for the Production of a Complex Polyketide
Application:
12/179,708 →
Aminoalkylazole Derivatives as Histamine-3 Antagonists
Application:
12/173,255 →